EP
TMDI

Eudaimonia Partners’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Eudaimonia Partners’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-49
Closed – – 1473
2021
Q1 		$0 Buy
+49
New +$110 ﹤0.01% 1674

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Accredited Investors Edina, Minnesota $2.31B AUM 33.7% 1-Year Est. Return
COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return

Eudaimonia Partners's TMDI Position: Q2 2021 in Review

Eudaimonia Partners sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q2 2021, closing a stake of 49 shares.

Eudaimonia Partners first reported a position in TMDI in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 60 funds tracked by Wall St. Rank hold TMDI as of Q2 2021.

  • Eudaimonia Partners reported no remaining Titan Medical Inc. Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 49 Titan Medical Inc. Ordinary Shares shares in Q2 2021.
  • Eudaimonia Partners first reported a position in Titan Medical Inc. Ordinary Shares in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Titan Medical Inc. Ordinary Shares position peaked at $0 in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.